🇺🇸 CG Oncology, Inc.CGON
Get CG Oncology, Inc. filings on Telegram the moment they are published.
Follow CG Oncology, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 7.01, 8.01, 9.01
Overview: Announced positive topline PIVOT-006 Phase 3 results for cretostimogene, showing a 68% reduction in recurrence risk for intermediate-risk and high-grade Ta NMIBC.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest